Press release
TurboGen Collaborates on Developing a Mobile Energy Production System for the Defense Industry
November 19, 2024 - TurboGen (TASE: TURB) (OTCPK: TURG.F), a leader in developing advanced innovative solutions for local energy production, is pleased to announce [https://www.linkedin.com/feed/update/urn:li:activity:7264610147996454916] the signing of a Memorandum of Understanding (MOU) with a leading Israeli defense company. The agreement, signed on November 19th 2024, focuses on integrating TurboGen's cutting-edge technology into a portable energy production system.
This collaboration leverages TurboGen's unique technology, which features high energy efficiency and superior performance. As validated by Technion laboratories [https://www.barchart.com/story/news/26468815/following-its-first-commercial-success-groundbreaking-trials-at-technion-laboratories-confirm-turbogen-tg40s-hydrogen-combustion-capabilities#google_vignette], TurboGen's systems operate effectively at high temperatures in combustion chambers powered by hydrogen, natural gas, diesel, and other green fuels. These capabilities enable the creation of compact and lightweight mobile energy systems, perfectly suited for field operations.
Yaron Gilboa, CEO of TurboGen, commented: "The signing of this MOU marks a major milestone in expanding the applications of our technology. The rising demand for efficient mobile energy solutions presents a strategic opportunity for TurboGen to enter new markets and offer reliable, independent energy systems where no power grid exists. We are proud to collaborate with a top-tier player in the defense sector, solidifying our reputation as a provider of innovative and dependable technology."
This partnership adds to TurboGen's recent milestones, including the first installation of its commercial system in New York, an MOU for system installations in Germany, and another MOU for installations in the U.S.
For full details please refer to TurboGen's filing [https://maya.tase.co.il/reports/details/1627625/2/0] on the ISA's Maya Site.
About TurboGen:
TurboGen (TASE: TURB) (OTCPK: TURG.F) specializes in developing advanced solutions for local energy production in buildings and various facilities. The company's innovative technology is designed to provide efficient, reliable, and environmentally friendly energy solutions, addressing the growing global demand for distributed power generation. For more information about the company: https://turbogenchp.com
About the Defense Company:
A leading defense company in Israel and globally, which is part of a large corporation that provides systemic solutions in both civilian and military domains. The corporation is a multinational technology company specializing in systems development and energy solutions for mobile systems designed for field conditions.
Forward-Looking Statements
Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. The Company undertakes no obligation to publicly update or revise any forward-looking statements .
Media Contact
Company Name: TurboGen CHP
Contact Person: Investor Contact
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=turbogen-collaborates-on-developing-a-mobile-energy-production-system-for-the-defense-industry]
Country: Israel
Website: https://turbogenchp.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release TurboGen Collaborates on Developing a Mobile Energy Production System for the Defense Industry here
News-ID: 3745133 • Views: …
More Releases from ABNewswire
Market Alert: BiomX Trading Surges Following Phase 2b Trial Initiation in Cystic …
Phage Therapy Developer Sees Stock Jump and Record Volume as Investors Recognize Potential in Novel Antimicrobial Approach (NYSE:PHGE)
Trading of BiomX Inc. (NYSE: PHGE) shares surged today following the company's announcement that it has successfully dosed the first patient in its Phase 2b trial evaluating BX004 for cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections. The stock movement seems to reflect growing investor confidence in the company's phage therapy platform…
Adpexai Breaks New Ground: Free Multi-Face Swap Video Platform Rises Beyond Deep …
In the world of digital content creation, face-swapping has become more than just a viral trend - it's now a core tool used for entertainment, marketing, parody, and personalisation. While deepfakes once dominated the scene, today's creators are looking for more practical, ethical, and user-friendly alternatives. This has led to the explosive rise of multiple face swap video online free platforms.
Now, with a few clicks, users can replace a face…
Global Medical Exoskeleton Market Size to Reach USD 538.4 Million in 2025, grow …
Medical exoskeletons [https://www.coherentmarketinsights.com/industry-reports/global-medical-exoskeleton-market] are wearable robotic systems designed to complement and amplify a user's natural movements, offering enhanced mobility assistance and increased strength. They empower individuals with mobility limitations or muscular weakness to stand upright, walk, lift heavier loads, and engage in both occupational and rehabilitative activities. The market for medical exoskeletons is expanding, fueled by rising rates of spinal cord injuries, the growing prevalence of orthopedic conditions, and an…
Global Consumer Genomics Market Size Hit USD 1.87 Billion by 2025, Growing at a …
Consumer Genomics [https://www.coherentmarketinsights.com/industry-reports/global-consumer-genomics-market] products generally fall into two main categories: at-home DNA testing kits and subscription-based genetic services. The kits enable users to collect saliva or cheek swabs at home, which are then shipped to a lab for analysis. The most popular direct-to-consumer options include ancestry tests-estimating ethnic heritage-and health predisposition tests-identifying genetic variants associated with conditions like cancer. As startups have driven down costs and improved accessibility, these tests…
